Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001831216-26-000005

Options or other derivatives

  • CH. DISCOV. & NON-CLIN DEV OFF acquired 356,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-02-02 Grant or award · Stock Option (Right to Buy) +250,000 250,000 D: show line 1 in the form
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF 2026-02-02 Grant or award · Performance Stock Options (Right to Buy) +106,250 106,250 D: show line 2 in the form
Loading xslF345X05/form4-02042026_090205.xml…